Siegel RL, et al. Cancer statistics, 2023. Ca Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Tan P, et al. Artificial intelligence aids in development of nanomedicines for cancer management. Amsterdam: Elsevier; 2023.

Book  Google Scholar 

Siegel RL, et al. Cancer statistics, 2022. CA A Cancer J Clin. 2022;72(1):7–33.

Article  Google Scholar 

Neoptolemos JP, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333–48.

Article  PubMed  Google Scholar 

Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol: WJG. 2015;21(11):3157.

Article  PubMed  PubMed Central  Google Scholar 

Chen X, et al. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18(11):804–23.

Article  PubMed  Google Scholar 

Haanen J, Committee EG, et al. Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017. https://doi.org/10.1093/annonc/mdx225.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riquelme E, Maitra A, McAllister F. Immunotherapy for pancreatic cancer: more than just a gut feeling. Cancer Discov. 2018;8(4):386–8.

Article  PubMed  Google Scholar 

Biankin AV, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399–405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pattanaik SK, et al. A mechanism-based perspective on the use of flavonoids in the treatment of diabetes and its complications. Curr Diabetes Rev. 2024. https://doi.org/10.2174/0115733998335480241022084655.

Article  PubMed  Google Scholar 

Yuan D, et al. Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: a novel delivery system perspective. Food Chem. 2024;430: 137115.

Article  CAS  PubMed  Google Scholar 

Helen H, et al. Flavonoids as modulators of miRNA expression in pancreatic cancer: pathways, mechanisms and therapeutic potential. Biomed Pharmacother. 2024;179: 117347.

Article  CAS  PubMed  Google Scholar 

Khan R, et al. Advances in nanomaterial-based immunosensors for prostate cancer screening. Biomed Pharmacother. 2022;155: 113649.

Article  CAS  PubMed  Google Scholar 

El-Tanani M, et al. Matrix metalloproteinase 2 is a target of the RAN-GTP pathway and mediates migration, invasion and metastasis in human breast cancer. Life Sci. 2022;310: 121046.

Article  CAS  PubMed  Google Scholar 

Haggag YA, et al. Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. Int J Pharm. 2017;521(1–2):40–53.

Article  CAS  PubMed  Google Scholar 

Sinha VR, Khosla L. Bioabsorbable polymers for implantable therapeutic systems. Drug Dev Ind Pharm. 1998;24(12):1129–38.

Article  CAS  PubMed  Google Scholar 

Basu A, et al. Poly (lactic acid) based hydrogels. Adv Drug Deliv Rev. 2016;107:192–205.

Article  CAS  PubMed  Google Scholar 

Stryer L, Berg JM, Tymoczko JL. Biochemistry and study guide. WH Freeman: New York NY USA; 2002.

Google Scholar 

Gullapalli S, Wong MS. Nanotechnology: a guide to nano-objects. Chem Eng Prog. 2011;107(5):28–32.

Google Scholar 

Lawson JC, Blatch GL, Edkins AL. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat. 2009;118(2):241–54.

Article  PubMed  Google Scholar 

Keyvani-Ghamsari S, et al. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance. Clin Epigenetics. 2021;13(1):1–31.

Article  Google Scholar 

Han J, et al. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev. 2020;49(22):7856–78.

Article  CAS  PubMed  Google Scholar 

Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23(10):1124–34.

Article  CAS  PubMed  Google Scholar 

Shackleton M, et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138(5):822–9.

Article  CAS  PubMed  Google Scholar 

Aponte PM, Caicedo A. Stemness in cancer: stem cells, cancer stem cells, and their microenvironment. Stem Cells Int. 2017. https://doi.org/10.1155/2017/5619472.

Article  PubMed  PubMed Central  Google Scholar 

Seoane J. Division hierarchy leads to cell heterogeneity. Nature. 2017;549(7671):164–6.

Article  CAS  PubMed  Google Scholar 

Kuşoğlu A, Avcı ÇB. Cancer stem cells: a brief review of the current status. Gene. 2019;681:80–5.

Article  PubMed  Google Scholar 

Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47–76.

Article  CAS  PubMed  Google Scholar 

Huang T, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10(19):8721.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemmati HD, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci. 2003;100(25):15178–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh SK, et al. Identification of a cancer stem cell in human brain tumors. Can Res. 2003;63(18):5821–8.

CAS  Google Scholar 

Collins AT, et al. Prospective identification of tumorigenic prostate cancer stem cells. Can Res. 2005;65(23):10946–51.

Article  CAS  Google Scholar 

Li C, et al. CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer. Theranostics. 2017;7(1):67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Brien CA, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106–10.

Article  PubMed  Google Scholar 

Todaro M, et al. IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle. 2008;7(3):309–13.

Article  CAS